4.8 Article

Fitness cost of antibiotic susceptibility during bacterial infection

Journal

SCIENCE TRANSLATIONAL MEDICINE
Volume 7, Issue 297, Pages -

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/scitranslmed.aab1621

Keywords

-

Funding

  1. Cystic Fibrosis Foundation [PIER14GO]
  2. AXA Research Fund
  3. Societe de Reanimation de Langue Francaise
  4. Conseil Regional de Champagne-Ardenne
  5. Philipp Fondation
  6. Association pour le Developpement de la Microbiologie et de l'Immunologie Remoises
  7. U.S. National Institute of Allergy and Infectious Diseases [AI-026289, AI-115962]
  8. Seedlings Foundation

Ask authors/readers for more resources

Advances in high-throughput DNA sequencing allow for a comprehensive analysis of bacterial genes that contribute to virulence in a specific infectious setting. Such information can yield new insights that affect decisions on how to best manage major public health issues such as the threat posed by increasing antimicrobial drug resistance. Much of the focus has been on the consequences of the selective advantage conferred on drug-resistant strains during antibiotic therapy. It is thought that the genetic and phenotypic changes that confer resistance also result in concomitant reductions in in vivo fitness, virulence, and transmission. However, experimental validation of this accepted paradigm is modest. Using a saturated transposon library of Pseudomonas aeruginosa, we identified genes across many functional categories and operons that contributed to maximal in vivo fitness during lung infections in animal models. Genes that bestowed both intrinsic and acquired antibiotic resistance provided a positive in vivo fitness advantage to P. aeruginosa during infection. We confirmed these findings in the pathogenic bacteria Acinetobacter baumannii and Vibrio cholerae using murine and rabbit infection models, respectively. Our results show that efforts to confront the worldwide increase in antibiotic resistance might be exacerbated by fitness advantages that enhance virulence in drug-resistant microbes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available